SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039836
Filing Date
2023-08-08
Accepted
2023-08-08 16:16:19
Documents
99
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q me-20230630.htm   iXBRL 10-Q 3065498
2 EX-31.1 me-ex31_1.htm EX-31.1 20699
3 EX-31.2 me-ex31_2.htm EX-31.2 20729
4 EX-32.1 me-ex32_1.htm EX-32.1 11465
5 EX-32.2 me-ex32_2.htm EX-32.2 15411
  Complete submission text file 0000950170-23-039836.txt   14269352

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT me-20230630_pre.xml EX-101.PRE 757727
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT me-20230630.xsd EX-101.SCH 115382
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT me-20230630_lab.xml EX-101.LAB 871273
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT me-20230630_def.xml EX-101.DEF 541176
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT me-20230630_cal.xml EX-101.CAL 53576
93 EXTRACTED XBRL INSTANCE DOCUMENT me-20230630_htm.xml XML 2924252
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-39587 | Film No.: 231151568
SIC: 2834 Pharmaceutical Preparations